Table 2. Baseline Characteristics and Biopsy Results Categorized in Different Baseline PSA Levels.
Variable | PSA 0.01–4.00 ng/ml | PSA 4.01–10.00 ng/ml | PSA >10.00 ng/ml | PSA unknown | Whole |
---|---|---|---|---|---|
No. of patients | 132 | 345 | 587 | 49 | 1113 |
Age (yr), mean ± SD (range) | 66.8±8.3 (37–86) | 68.6±8.5 (26–91) | 71.4±7.8 (37–89) | 71.4±8.7 (42–84) | 70.0±8.3 (26–91) |
No. of patients biopsied within three months (rate) | 31 (23.5%) | 142 (41.2%) | 409 (69.7%) | 4 (8.2%) | 586 (52.7%) |
No. of patients biopsied positive within three months (rate) | 6 (6/31, 19.4%) | 55 (55/142, 38.7%) | 278 (278/409, 68.0%) | 1 (1/4, 25.0%) | 340 (340/586, 58.0%) |
PSA: prostate specific antigen.